Boston Scientific backs mitral valve developer 4C Medical in $175M round
Boston Scientific led a $175 million funding round for 4C Medical, which is taking a different approach to mitral regurgitation.

Mar 8, 2025 0
Mar 8, 2025 0
Mar 8, 2025 0
Mar 7, 2025 0
Mar 8, 2025 0
Mar 8, 2025 0
Mar 7, 2025 0
Mar 7, 2025 0
Mar 7, 2025 0
Mar 7, 2025 0
Mar 8, 2025 0
Mar 8, 2025 0
Mar 4, 2025 0
Mar 2, 2025 0
Mar 2, 2025 0
Mar 4, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Mar 7, 2025 0
Mar 7, 2025 0
Mar 7, 2025 0
Mar 7, 2025 0
Or register with email
Feb 9, 2025 0
Feb 10, 2025 0
Feb 11, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 13, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.